Product image of Levetiracetam Terapia (Levetiracetam) supplied by GNH India

Levetiracetam Terapia

Active Ingredient:
Levetiracetam
Origin:
EU

Levetiracetam Terapia (Levetiracetam)

Levetiracetam, the active ingredient in Levetiracetam Terapia, is an anticonvulsant presented as an oral tablet for oral use. It is employed to manage various seizure types in patients with epilepsy, including partial, generalized tonic‑clonic and myoclonic seizures.

GNH India supplies Levetiracetam Terapia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for healthcare providers across multiple regions. All shipments are accompanied by full documentation to facilitate regulatory compliance.

Manufacturer / TM Owner

Terapia S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levetiracetam is an antiepileptic drug that reduces seizure activity across several seizure types.

  • Partial seizures: reduces frequency of focal onset seizures in patients with epilepsy.
  • Generalized tonic‑clonic seizures: helps control convulsive seizures that involve the whole brain.
  • Myoclonic seizures: decreases sudden muscle jerks associated with myoclonic epilepsy.

How It Works

  • Levetiracetam binds to the synaptic vesicle protein SV2A, a key regulator of neurotransmitter release. This interaction modulates vesicle exocytosis, stabilizing neuronal membranes and diminishing hyper‑excitability. By reducing the release of excitatory neurotransmitters, the drug lowers the likelihood of synchronous neuronal firing that underlies seizure generation. The precise downstream pathways remain under investigation, but the overall effect is a net decrease in neuronal firing rates during epileptic events.

Side Effects

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Dizziness: sensation of light‑headedness or unsteadiness, often transient.
  • Fatigue: feeling unusually tired or lacking energy, may affect daily activities.
  • Headache: mild to moderate cranial pain that can be intermittent.
  • Irritability: mood changes including increased agitation or restlessness.

Serious or Rare Side Effects

  • Severe allergic reaction: rash, swelling, or difficulty breathing requiring immediate medical attention.
  • Mood or behavior changes: depression, suicidal thoughts, aggression, or hostility that may emerge suddenly.
  • Blood disorders: thrombocytopenia or leukopenia, presenting as easy bruising or increased infection risk.

Precautions & Warnings

When prescribing Levetiracetam, several precautions should be considered to ensure safe use.

  • Renal impairment: adjust dose in patients with reduced kidney function.
  • History of psychiatric disorders: monitor for mood changes or aggression.
  • Concomitant CNS depressants: use caution as combined effects may increase sedation.
  • Pregnancy: risk unknown; evaluate benefit‑risk before use.
  • Driving and machinery: advise patients that dizziness or fatigue may affect performance.
  • Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture.

Avoid Interactions

Levetiracetam can interact with other medicines, influencing its effectiveness or safety.

Major Interactions (Avoid)

  • Carbamazepine: may reduce levetiracetam plasma levels, decreasing efficacy.
  • Phenobarbital: can lower levetiracetam concentrations, requiring monitoring.

Moderate Interactions (Monitor Closely)

  • Valproic acid: may increase risk of central nervous system side effects.
  • Fluoroquinolones: potential for enhanced neurotoxicity, watch for tremor or confusion.
  • Opioids: combined use may augment sedation and respiratory depression.

Frequently Asked Questions

Levetiracetam Terapia is prescribed to treat epilepsy by reducing the frequency of partial, generalized tonic‑clonic, and myoclonic seizures. It is used in patients who require long‑term seizure control and is part of standard antiepileptic therapy.

Levetiracetam binds to the synaptic vesicle protein SV2A, which plays a key role in neurotransmitter release. This binding modulates vesicle exocytosis, stabilising neuronal membranes and decreasing the release of excitatory neurotransmitters, thereby lowering neuronal hyper‑excitability that leads to seizures.

The appropriate dose of Levetiracetam Terapia is determined by the prescribing clinician based on the individual’s seizure type, severity, renal function, age, and response to therapy. Dosage adjustments are made according to clinical judgement and patient monitoring.

Levetiracetam is classified with an unknown pregnancy category, meaning the risk to the fetus is not fully established. Healthcare providers must weigh potential benefits against possible risks, and breastfeeding mothers should consult a physician before using the medication.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with many traditional antiepileptics, levetiracetam has a relatively simple pharmacokinetic profile, minimal protein binding and fewer drug‑enzyme interactions. It is often favoured for patients who need a medication with fewer metabolic concerns, though individual response varies.

Levetiracetam tablets should be stored at ambient temperature, below 25 °C, in the original container to protect from moisture and light. Keep the product out of reach of children and avoid exposure to extreme heat or humidity.

Levetiracetam is taken orally, usually as a tablet, with or without food. The exact timing and frequency are set by the prescriber, who may recommend consistent dosing intervals to maintain stable blood levels.

Serious risks include severe allergic reactions such as rash or swelling, significant mood or behavioural changes like depression or suicidal thoughts, and rare blood disorders such as thrombocytopenia. Patients should seek immediate medical attention if any of these occur.

Levetiracetam is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is advised for patients with severe renal impairment, uncontrolled psychiatric conditions, or those taking interacting medications listed under major interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levetiracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT